Seborrhoeic dermatitis

Seborrhoeic dermatitis
Other namesSebopsoriasis, seborrhoeic eczema, pityriasis capitis
Seborrhoeic dermatitis of the face
SpecialtyDermatology
SymptomsFlaking, dry or greasy, red, itchy, and inflamed skin
DurationSeveral weeks to lifelong
CausesMultiple factors
Risk factorsStress, dry skin, winter, poor immune function, Parkinson disease
Diagnostic methodBased on symptoms
Differential diagnosisPsoriasis, atopic dermatitis, tinea capitis, rosacea, systemic lupus erythematosus
TreatmentHumidifier
MedicationAntifungal cream, anti-inflammatory agents, coal tar, phototherapy
Frequency~5% (adults), ~10% (babies)

Seborrhoeic dermatitis (also spelled seborrheic dermatitis in American English) is a long-term skin disorder. Symptoms include flaky, scaly, greasy, and occasionally itchy and inflamed skin. Areas of the skin rich in oil-producing glands are often affected including the scalp, face, and chest. It can result in social or self-esteem problems. In babies, when the scalp is primarily involved, it is called cradle cap. Mild seborrhoeic dermatitis of the scalp may be described in lay terms as dandruff due to the dry, flaky character of the skin. However, as dandruff may refer to any dryness or scaling of the scalp, not all dandruff is seborrhoeic dermatitis. Seborrhoeic dermatitis is sometimes inaccurately referred to as seborrhoea.

The cause is unclear but believed to involve a number of genetic and environmental factors. Risk factors for seborrhoeic dermatitis include poor immune function, Parkinson's disease, and alcoholic pancreatitis. The condition may worsen with stress or during the winter. Malassezia yeast is believed to play a role. It is not a result of poor hygiene. Diagnosis is typically clinical and based on the symptoms present. The condition is not contagious.

The typical treatment is topical antifungal cream and anti-inflammatory agents. Specifically, ketoconazole or ciclopirox are effective. Seborrhoeic dermatitis of the scalp is often treated with shampoo preparations of ketoconazole, zinc pyrithione, and selenium, although the latter has been partly discontinued due to concerns of selenium in higher concentrations being carcinogenic.

The condition is common in infants within the first three months of age or adults aged 30 to 70 years. It tends to affect more males. Seborrhoeic dermatitis is more common in African Americans, among immune-compromised individuals, such as those with HIV, and individuals with Parkinson's disease.